In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy

In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy

High-risk non-metastatic prostate cancer (PCa) has the potential to progress into lethal disease. Treatment options are manifold but, given a lack of surrogate biomarkers, it remains unclear which treatment offers the best results. Several studies have reported circulating tumor cells (CTCs) to be a...

Full description

Bibliographic Details
Main Authors: Shukun Chen, Gerlinde Tauber, Tanja Langsenlehner, Linda Maria Schmölzer, Michaela Pötscher, Sabine Riethdorf, Andra Kuske, Gerd Leitinger, Karl Kashofer, Zbigniew T. Czyż, Bernhard Polzer, Klaus Pantel, Peter Sedlmayr, Thomas Kroneis, Amin El-Heliebi
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Cancers
Subjects:
circulating tumor cells
in vivo detection
non-metastatic prostate cancer
radiotherapy
Online Access:https://www.mdpi.com/2072-6694/11/7/933

Similar Items

Similar Items